Amlodipine Besylate Tablet
Product Images NDC 70518-0835

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 70518-0835). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for AMLODIPINE BESYLATE 5 mg oral tablets, containing 30 tablets. The label shows the proprietary and generic name, strength, dosage form, and quantity. It is Rx only with NDC 70518-0835-00. Manufactured by Cipla USA, Inc. and repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions and a barcode are also visible.*

FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 01

Chemical structure of amlodipine besylate showing the arrangement of atoms and bonds including elements such as chlorine, nitrogen, oxygen, and sulfur. The structure includes a bicyclic ring system, ester groups, and an amine functional group.*

FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 02

A line graph comparing event rates over 24 months for Amlodipine versus placebo. The x-axis shows time in months, and the y-axis shows event rate. Two cumulative event curves are labeled 'Amlodipine' and 'Placebo' with Amlodipine's line consistently lower. A statistical box indicates a p-value of 0.003, hazard ratio of 0.691, and 95% confidence interval of 0.54 to 0.88.*

FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 03

A forest plot illustrating hazard ratios with 95% confidence intervals comparing the effect of Amlodipine versus placebo across various patient subgroups. The subgroups include all patients, age groups, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The horizontal axis represents the hazard ratio scale from 0.0 to 2.0, with markers indicating the direction favoring Amlodipine or placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.